Now available at Grovet with Belgian registration!
Danilon contains suxibuzone, a prodrug of phenylbutazone, and is the only preparation registered in Belgium with this active substance. Danilon is indicated for the supportive treatment of musculoskeletal disorders in horses and ponies, such as laminitis and osteoarthritis. It is a new veterinary medicinal product for equine practitioners in Belgium and a valuable addition to the available NSAID range for horses.
Suxibuzone as a valuable alternative to phenylbutazone
A field study demonstrated that suxibuzone is equally effective as phenylbutazone in the treatment of lameness. This conclusion is supported by the BEVA analgesia guidelines, in which suxibuzone is recognised as a valid alternative to phenylbutazone in cases of chronic
